Physician profile
Sonali M Smith
NPI 1215153226
$35,232.76
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $8,178 · 2021: $4,062 · 2023: $81.20 · 2024: $8,339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,113 · Food and Beverage: $284 · Education: $23.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,113.25 |
| Food and Beverage | $283.57 |
| Education | $23.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $9,186.37 | 2019-2020 | |
| Regeneron Pharmaceuticals, INC. | $5,562.00 | 2024 | |
| Genentech, INC. | $4,986.10 | 2019 | |
| Gilead Sciences, INC. | $2,850.00 | 2021 | |
| Genmab U.S., INC. | $2,777.12 | 2024 | Epkinly |
| Janssen Global Services, LLC | $2,525.00 | 2020 | |
| Incyte Corporation | $1,845.00 | 2020 | |
| Karyopharm Therapeutics INC. | $1,488.00 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $1,400.00 | 2019 | |
| F. Hoffmann-La Roche Ag | $1,320.00 | 2019 | |
| Adaptive Biotechnologies Corporation | $1,200.00 | 2021 | |
| Abbvie INC. | $57.70 | 2023 | Epkinly |
| Kyowa Kirin, INC. | $23.50 | 2023 | Poteligeo |
| Acrotech Biopharma INC. | $11.97 | 2021 |
9 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonali Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.